Marianne P. Allen

Array ( [id] => 5787057 [patent_doc_number] => 20060205925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Streptoccal inhibitor of complement-mediated lysis, protein SIC' [patent_app_type] => utility [patent_app_number] => 11/418770 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10119 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205925.pdf [firstpage_image] =>[orig_patent_app_number] => 11418770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92210 [patent_doc_number] => 07737115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'HGF beta chain variants' [patent_app_type] => utility [patent_app_number] => 11/406067 [patent_app_country] => US [patent_app_date] => 2006-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 21230 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737115.pdf [firstpage_image] =>[orig_patent_app_number] => 11406067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988139 [patent_doc_number] => 20070154478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Therapeutic composition' [patent_app_type] => utility [patent_app_number] => 11/401321 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10092 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154478.pdf [firstpage_image] =>[orig_patent_app_number] => 11401321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318502 [patent_doc_number] => 07521211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/395706 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7064 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521211.pdf [firstpage_image] =>[orig_patent_app_number] => 11395706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778289 [patent_doc_number] => 20080286287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Methods and Agents for Modulating Cellular Activity' [patent_app_type] => utility [patent_app_number] => 11/910406 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22920 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286287.pdf [firstpage_image] =>[orig_patent_app_number] => 11910406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656464 [patent_doc_number] => 20060142200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia' [patent_app_type] => utility [patent_app_number] => 11/361788 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12454 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142200.pdf [firstpage_image] =>[orig_patent_app_number] => 11361788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148695 [patent_doc_number] => 20070048754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Epidermal growth factor receptor mutations' [patent_app_type] => utility [patent_app_number] => 11/361711 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 32980 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048754.pdf [firstpage_image] =>[orig_patent_app_number] => 11361711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307457 [patent_doc_number] => 07531523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Sodium channel protein type III alpha-subunit splice variant' [patent_app_type] => utility [patent_app_number] => 11/357518 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23305 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531523.pdf [firstpage_image] =>[orig_patent_app_number] => 11357518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270362 [patent_doc_number] => 08211864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors' [patent_app_type] => utility [patent_app_number] => 11/814890 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 23630 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11814890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 178053 [patent_doc_number] => 07655762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Monoclonal antibodies against ANGPTL4' [patent_app_type] => utility [patent_app_number] => 11/327844 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 49 [patent_no_of_words] => 35441 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655762.pdf [firstpage_image] =>[orig_patent_app_number] => 11327844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056799 [patent_doc_number] => 20070059721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'MAGI polynucleotides, polypeptides, and antibodies' [patent_app_type] => utility [patent_app_number] => 11/316490 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10219 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059721.pdf [firstpage_image] =>[orig_patent_app_number] => 11316490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834241 [patent_doc_number] => 20060246071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Antibodies directed to angiopoietin-2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/311939 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 49407 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246071.pdf [firstpage_image] =>[orig_patent_app_number] => 11311939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567438 [patent_doc_number] => 07858341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'FGF18 production in prokaryotic hosts' [patent_app_type] => utility [patent_app_number] => 11/301383 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25397 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858341.pdf [firstpage_image] =>[orig_patent_app_number] => 11301383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12930922 [patent_doc_number] => 09829494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Methods of treatment using ADM antibodies [patent_app_type] => utility [patent_app_number] => 12/095675 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7149 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753933 [patent_doc_number] => 20060223082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Map' [patent_app_type] => utility [patent_app_number] => 11/271616 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14724 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223082.pdf [firstpage_image] =>[orig_patent_app_number] => 11271616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688929 [patent_doc_number] => 20070105769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Methods of treating tissue defects' [patent_app_type] => utility [patent_app_number] => 11/268699 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5136 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105769.pdf [firstpage_image] =>[orig_patent_app_number] => 11268699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676820 [patent_doc_number] => 20080214451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'G Protein Coupled Receptor Agonists and Antagonists and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/667042 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 23497 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214451.pdf [firstpage_image] =>[orig_patent_app_number] => 11667042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995094 [patent_doc_number] => 20070010439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Production of human parathyroid hormone from microorganisms' [patent_app_type] => utility [patent_app_number] => 11/247585 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13301 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010439.pdf [firstpage_image] =>[orig_patent_app_number] => 11247585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820719 [patent_doc_number] => 07408052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Nucleic acid molecules and other molecules associated with the carbon assimilation pathway' [patent_app_type] => utility [patent_app_number] => 11/244330 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 159887 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408052.pdf [firstpage_image] =>[orig_patent_app_number] => 11244330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5012980 [patent_doc_number] => 20070283459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Nucleic acid molecules and other molecules associated with plants' [patent_app_type] => utility [patent_app_number] => 11/239591 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31712 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0283/20070283459.pdf [firstpage_image] =>[orig_patent_app_number] => 11239591 [rel_patent_id] =>[rel_patent_doc_number] =>)